verapamil has been researched along with thromboxane a2 in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (41.67) | 18.7374 |
| 1990's | 17 (47.22) | 18.2507 |
| 2000's | 4 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiyotani, A; Isono, K; Kondo, M; Konno, K; Sakai, N; Tamaoki, J | 1 |
| Haught, WH; Lawson, DL; Mehta, JL; Yang, BC | 1 |
| Aliev, MA; Bekbolotova, AK; Lemeshenko, VA | 1 |
| Gill, JR; Keiser, H; Ohman, KP; Yun, JC | 1 |
| Abbate, R; Boddi, M; Coppo, M; Gensini, GF; Neri Serneri, GG; Prisco, D; Rostagno, C | 1 |
| Furui, H; Furumichi, T; Hayashi, H; Saito, H; Suzuki, T; Yamada, Y; Yamauchi, K; Yokota, M | 1 |
| Abbate, R; Boddi, M; Costanzo, G; Paniccia, R; Poggesi, L; Prisco, D; Rostagno, C | 1 |
| Francis, GS; Johnson, GJ; Leis, LA | 2 |
| Kawaguchi, H; Takahashi, K; Yasuda, H | 1 |
| Escalante, B; Reyes, JL | 1 |
| Alfredson, ML; Armour, CL; Black, JL; Johnson, PR | 1 |
| Compton, MR; Ozols, S; Seale, JP; Shaw, J | 1 |
| Hall, ED; Wolf, DL | 1 |
| Takahashi, K | 1 |
| Iwanov, V; Moulds, RF; Young, MS | 1 |
| Mallarkey, G; Smith, GM | 1 |
| Lefer, AM; Nicolaou, KC; Smith, EF | 1 |
| Honn, KV; Onoda, JM; Sloane, BF | 1 |
| Toda, N | 2 |
| Crews, F; Mehta, J; Mehta, P; Ostrowski, N | 1 |
| Andriani, A; Chiappetta, MG; Fabiani, M | 1 |
| Izawa, T; Izumi, H; Kasai, H; Ogawa, N; Okada, Y; Yokoyama, T | 1 |
| Han, SZ; Karaki, H; Orimo, H; Ouchi, Y; Stergiopoulos, K; Tabata, RE | 1 |
| Li, ZY; Lian, EC; Yu, TF | 1 |
| Aljada, A; Dandona, P; Khurana, U; Love, J; Mousa, S; Thusu, K | 1 |
| Nam, KY; Park, HJ; Park, KH; Park, KM; Rhee, MH | 1 |
| Abe, A; Hori, M; Karaki, H; Kinoshita, M; Mitsui-Saito, M; Ozaki, H; Uehigashi, Y | 1 |
| Hu, DH; Ma, CT | 1 |
| Paul, RJ; Rapoport, RM; Tosun, M | 1 |
| Afzal, MN; Saeed, SA; Shah, BH | 1 |
| Diener, M; Frings, M; Haschke, G; Heinke, B; Schäfer, KH | 1 |
| Hanif, S; Khan, FL; Rahman, HB; Rahman, IH; Rasheed, H; Saeed, SA; Shah, BH; Shariff, AH | 1 |
| Rasheed, H; Saeed, SA | 1 |
| Matic, M; Milic, N; Perunicic, J; Simic, T; Soskic, L; Vranic, II | 1 |
1 review(s) available for verapamil and thromboxane a2
| Article | Year |
|---|---|
[Platelet aggregation and antiaggregant drugs].
Topics: Dipyridamole; Humans; Papaverine; Platelet Aggregation; Prostaglandins; Theophylline; Thiophenes; Thromboxane A2; Ticlopidine; Verapamil | 1982 |
2 trial(s) available for verapamil and thromboxane a2
| Article | Year |
|---|---|
Effects of calcium channel blockers on platelet aggregation and thromboxane A2 formation: an in vivo double blind randomized study.
Topics: Adult; Blood Platelets; Calcium Channel Blockers; Diltiazem; Double-Blind Method; Female; Humans; Male; Middle Aged; Nifedipine; Platelet Aggregation; Thromboxane A2; Verapamil | 1990 |
Adenosine cardioprotection study in clinical setting of paroxysmal supraventricular tachycardia.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine; Adult; Cardiotonic Agents; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Prostaglandins; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Thromboxane A2; Thromboxane B2; Verapamil | 2006 |
33 other study(ies) available for verapamil and thromboxane a2
| Article | Year |
|---|---|
Thromboxane A2 mimetic U46619 stimulates ciliary motility of rabbit tracheal epithelial cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; Cilia; Cyclic AMP; Dose-Response Relationship, Drug; Epithelial Cells; Epithelium; Fatty Acids, Unsaturated; Hydrazines; Isoproterenol; Isoquinolines; Male; Movement; Piperazines; Prostaglandin Endoperoxides, Synthetic; Protein Kinase C; Rabbits; Thromboxane A2; Trachea; Verapamil | 1992 |
Slow channel calcium blockers attenuate reoxygenation-mediated vascular contraction, but augment anoxia-mediated vascular contraction.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Aorta; Diltiazem; In Vitro Techniques; Indomethacin; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Oxygen; Oxyhemoglobins; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Thromboxane A2; Vasoconstriction; Verapamil | 1992 |
[Prostacyclin-thromboxane imbalance after adrenergic damage of the heart and aorta and its correction with calcium antagonist finoptin and the adaptation to high-altitude climate].
Topics: Adaptation, Physiological; Altitude; Animals; Aorta, Abdominal; Disease Models, Animal; Epinephrine; Epoprostenol; Male; Myocardium; Necrosis; Platelet Aggregation; Rats; Thromboxane A2; Verapamil | 1992 |
Effects of prostaglandins, cAMP, and changes in cytosolic calcium on platelet aggregation induced by a thromboxane A2 mimic (U46619).
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Bucladesine; Calcium; Calcium Channel Blockers; Colforsin; Cyclic AMP; Cytosol; Egtazic Acid; Female; Gallic Acid; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Prostaglandins; Thromboxane A2; Verapamil | 1991 |
In vitro effects of two novel calcium antagonists (nitrendipine and nisoldipine) on intraplatelet calcium redistribution, platelet aggregation and thromboxane A2 formation. Comparison with diltiazem, nifedipine and verapamil.
Topics: Adult; Blood Platelets; Calcium; Calcium Channel Blockers; Diltiazem; Female; Humans; In Vitro Techniques; Male; Nifedipine; Nisoldipine; Nitrendipine; Platelet Aggregation; Thromboxane A2; Thromboxane B2; Verapamil | 1991 |
Inhibitory effects of endothelial cells and calcium channel blockers on platelet aggregation.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Aspirin; Blood Platelets; Bone Marrow Cells; Calcium Channel Blockers; Collagen; Diltiazem; Endothelium, Vascular; Epoprostenol; Fibroblasts; Humans; Nicardipine; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombin; Thromboxane A2; Verapamil | 1990 |
Adenosine potentiates the inhibitory effects of calcium channel antagonists on human platelet aggregation induced by thromboxane A2 or U46619.
Topics: Adenosine; Alprostadil; Calcium Channel Blockers; Diltiazem; Drug Synergism; Epinephrine; Humans; In Vitro Techniques; Nifedipine; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Thromboxane A2; Verapamil | 1990 |
The hypertensive response to vasopressor agents stimulates the release of thromboxane A2 in hypercholesterolaemic rabbits.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Blood Pressure; Dose-Response Relationship, Drug; Epoprostenol; Ergonovine; Hypercholesterolemia; Nitroglycerin; Norepinephrine; Rabbits; Thromboxane A2; Thromboxane B2; Verapamil | 1989 |
Intracellular mechanisms of the effect of thromboxane A2 on water transport.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Body Water; Calcium; Cell Line; Colchicine; Kidney; Kinetics; Prostaglandin Endoperoxides, Synthetic; Thromboxane A2; Trifluoperazine; Verapamil | 1989 |
Characterization of contractile prostanoid receptors on human airway smooth muscle.
Topics: Atropine; Biphenyl Compounds; Bronchi; Carbachol; Dinoprost; Dinoprostone; Heptanoic Acids; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Prostaglandin Endoperoxides, Synthetic; Receptors, Prostaglandin; Thromboxane A2; Verapamil | 1989 |
Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Chromatography, Gel; Collagen; Cyclic AMP; Drug Synergism; Epinephrine; Humans; Nifedipine; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Receptors, Adrenergic, alpha; Thromboxane A2; Tritium; Verapamil; Yohimbine | 1986 |
Effects of verapamil on activation of arachidonic acid metabolism in guinea-pig lungs.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Biotransformation; Calcium; Edetic Acid; Guinea Pigs; Histamine; In Vitro Techniques; Leukotriene E4; Lung; Male; Muscle, Smooth, Vascular; SRS-A; Stereoisomerism; Thromboxane A2; Verapamil | 1986 |
A pharmacological analysis of the pathophysiological mechanisms of posttraumatic spinal cord ischemia.
Topics: Animals; Benzofurans; Calcium Channel Blockers; Cats; Cyclooxygenase Inhibitors; Diltiazem; Dinoprost; Epoprostenol; Female; Ibuprofen; Ischemia; Male; Meclofenamic Acid; Nifedipine; Prostaglandin Antagonists; Prostaglandins F; Spinal Cord; Thromboxane A2; Verapamil; Vitamin E | 1986 |
[The release of thromboxane A2 and prostacyclin due to vasoactive agents in hypercholesterolemic rabbits].
Topics: Angiotensin II; Animals; Blood Pressure; Epoprostenol; Ergonovine; Hypercholesterolemia; Nitroglycerin; Norepinephrine; Rabbits; Thromboxane A2; Verapamil | 1986 |
Interaction between platelet-released serotonin and thromboxane A2 on human digital arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arteries; Blood Platelets; Calcium; Drug Synergism; Humans; In Vitro Techniques; Nifedipine; Prostaglandin Endoperoxides, Synthetic; Serotonin; Thromboxane A2; Verapamil | 1986 |
The involvement of platelets and the coronary vasculature in collagen-induced sudden death in rabbits.
Topics: Animals; Blood Platelets; Collagen; Coronary Vessels; Female; Male; Platelet Aggregation; Rabbits; Thromboxane A2; Vasoconstriction; Verapamil | 1985 |
Mechanism of coronary vasoconstriction induced by carbocyclic thromboxane A2.
Topics: Animals; Calcium; Cats; Coronary Vessels; Female; Male; Nifedipine; Receptors, Adrenergic, alpha; Receptors, Angiotensin; Thromboxane A2; Thromboxanes; Vasoconstriction; Verapamil | 1981 |
Antithrombogenic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthase inhibitors.
Topics: Adenosine Diphosphate; Benzofurans; Blood Platelets; Calcium Channel Blockers; Diltiazem; Drug Synergism; Epoprostenol; Humans; Nicotinic Acids; Nifedipine; Nimodipine; Oxidoreductases; Platelet Aggregation; Thrombin; Thromboxane A2; Thromboxane-A Synthase; Verapamil | 1984 |
Responses of human, monkey and dog coronary arteries in vitro to carbocyclic thromboxane A2 and vasodilators.
Topics: Adult; Aged; Animals; Coronary Vessels; Dinoprost; Dogs; Epoprostenol; Female; Humans; In Vitro Techniques; Macaca; Male; Middle Aged; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroglycerin; Polyphloretin Phosphate; Prostaglandins F; Species Specificity; Thromboxane A2; Thromboxanes; Vasodilator Agents; Verapamil | 1984 |
Effects of verapamil on platelet aggregation, ATP release and thromboxane generation.
Topics: Adenosine Triphosphate; Adult; Blood Platelets; Humans; Platelet Aggregation; Thromboxane A2; Thromboxanes; Verapamil | 1983 |
Mechanism of action of carbocyclic thromboxane A2 and its interaction with prostaglandin I2 and verapamil in isolated arteries.
Topics: Animals; Arteries; Cerebral Arteries; Coronary Vessels; Dogs; Epoprostenol; Female; Femoral Artery; Macaca; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Prostaglandins; Renal Artery; Thromboxane A2; Thromboxanes; Vasoconstriction; Verapamil | 1982 |
Effect of Kil769, a novel K(+)-channel opener, on sensitivity to Ca2+ of contractile elements and inositol phosphate formation in porcine coronary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Calcium; Calcium Channel Blockers; Coronary Vessels; Dose-Response Relationship, Drug; Fura-2; Glyburide; Hydrolysis; In Vitro Techniques; Inositol Phosphates; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Potassium Channels; Prostaglandin Endoperoxides, Synthetic; Pyridines; Swine; Thromboxane A2; Vasoconstrictor Agents; Vasodilator Agents; Verapamil | 1995 |
Calcium channel blocking substances for prevention of atherosclerosis.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arteriosclerosis; Calcium; Calcium Channel Blockers; Diet, Atherogenic; Estradiol; Magnesium; Male; Myocardial Contraction; Prostaglandin Endoperoxides, Synthetic; Rabbits; Rats; Rats, Wistar; Swine; Thromboxane A2; Verapamil | 1995 |
Purification and characterization of L-amino acid oxidase from king cobra (Ophiophagus hannah) venom and its effects on human platelet aggregation.
Topics: Alprostadil; Amino Acid Oxidoreductases; Animals; Antimycin A; Aspirin; Blood Coagulation Tests; Blood Platelets; Catalase; Chromatography, Gel; Chromatography, Ion Exchange; Drug Interactions; Edetic Acid; Elapid Venoms; Electrophoresis, Polyacrylamide Gel; Heparin; Hirudins; Humans; Hydrogen Peroxide; Indomethacin; Isoelectric Point; L-Amino Acid Oxidase; Molecular Weight; Nitroprusside; Platelet Aggregation; Quinacrine; Thromboxane A2; Verapamil | 1994 |
Calcium, calmodulin and protein kinase C dependence of platelet shape change.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Binding Sites; Blood Platelets; Calcium; Calcium Channel Blockers; Calmodulin; Cell Size; Chelating Agents; Edetic Acid; Gallic Acid; Humans; Intracellular Fluid; Mesylates; Peptides, Cyclic; Platelet Activation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Protein Kinase C; Thromboxane A2; Vasoconstrictor Agents; Verapamil | 1996 |
Effect of non-saponin fraction from Panax ginseng on cGMP and thromboxane A2 in human platelet aggregation.
Topics: Alkynes; Blood Platelets; Calcium; Calcium Channel Blockers; Cyclic AMP; Cyclic GMP; Diynes; Fatty Alcohols; Humans; Molsidomine; Panax; Plant Extracts; Plants, Medicinal; Platelet Aggregation Inhibitors; Thrombin; Thromboxane A2; Vasodilator Agents; Verapamil | 1995 |
Effects of a prostaglandin I2 analog iloprost on cytoplasmic Ca2+ levels and muscle contraction in isolated guinea pig aorta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta; Calcium; Cyclic AMP; Dinoprost; Dose-Response Relationship, Drug; Guinea Pigs; Iloprost; In Vitro Techniques; Indomethacin; Male; Muscle, Smooth, Vascular; Prostaglandin Endoperoxides, Synthetic; Thromboxane A2; Vasoconstriction; Verapamil | 1996 |
[Effect of platelet activating factor on TxA2, PGI2 and Ca(2+)-ATPase activity in the intra-pulmonary artery smooth muscle cells].
Topics: Animals; Calcium-Transporting ATPases; Cells, Cultured; Epoprostenol; Indomethacin; Muscle, Smooth, Vascular; Platelet Activating Factor; Pulmonary Artery; Rabbits; Thromboxane A2; Verapamil | 1996 |
Intracellular Ca2+ elevation and contraction due to prostaglandin F2alpha in rat aorta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta, Thoracic; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Calcium Channel Blockers; Calcium Channels; Dinoprost; Fatty Acids, Unsaturated; Hydrazines; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Thromboxane A2; Verapamil | 1997 |
Dual effects of nimesulide, a COX-2 inhibitor, in human platelets.
Topics: Blood Platelets; Calcium Channel Blockers; Cyclooxygenase Inhibitors; Diltiazem; Dose-Response Relationship, Drug; Drug Synergism; Epinephrine; Humans; Nitric Oxide Donors; Penicillamine; Platelet Aggregation; Platelet Aggregation Inhibitors; Sulfonamides; Thromboxane A2; Verapamil | 1998 |
Spontaneous contractions of intestinal smooth muscle re-aggregates from the new-born rat triggered by thromboxane A2.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Animals, Newborn; Calcium; Carbachol; Carbazoles; Cell Aggregation; Cholinergic Agonists; Fluorescent Dyes; Fura-2; Intestine, Small; Microscopy, Fluorescence; Muscle Contraction; Muscle, Smooth; Platelet Aggregation Inhibitors; Rats; Sulfonamides; Tetrodotoxin; Thromboxane A2; Vasoconstrictor Agents; Verapamil | 2000 |
Molecular mechanisms involved in human platelet aggregation by synergistic interaction of platelet-activating factor and 5-hydroxytryptamine.
Topics: Diltiazem; Dose-Response Relationship, Drug; Drug Synergism; Estrenes; Flavonoids; Humans; In Vitro Techniques; Indomethacin; Kinetics; Mitogen-Activated Protein Kinases; Phosphorylation; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Pyrrolidinones; Serotonin; Thromboxane A2; Verapamil | 2001 |
Involvement of thromboxane A2 and tyrosine kinase in the synergistic interaction of platelet activating factor and calcium ionophore A23187 in human platelet aggregation.
Topics: Benzoquinones; Blood Platelets; Calcimycin; Humans; Indomethacin; Ionophores; Lactams, Macrocyclic; Platelet Activating Factor; Platelet Aggregation; Protein-Tyrosine Kinases; Quinones; Rifabutin; Thromboxane A2; Verapamil | 2004 |